SH
Satveek Hanumant Giramkar
About Satveek Hanumant Giramkar
Data last updated:
Satveek Hanumant Giramkar is a Director at Danlion Pharmaceuticals Private Limited (since 2017). The company operates in Service. Danlion Pharmaceuticals Private Limited reported revenue of ₹3.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Danlion Pharmaceuticals Private Limited U93090PN2017PTC171285 | Director | 05 Jul 2017 | 2017 | ₹3.17 Cr (FY 2025) | Active |
Board colleagues of Satveek Hanumant Giramkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jitendra Kalpnath Singh | 07869455 | Danlion Pharmaceuticals Private Limited | Director |
| Premchand Ramchandra Bhusanar | 07869454 | Danlion Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satveek Hanumant Giramkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satveek Hanumant Giramkar
Satveek Hanumant Giramkar currently holds 1 directorship: Danlion Pharmaceuticals Private Limited (Director, since 05 Jul 2017, revenue ₹3.17 Cr (FY 2025)).
Satveek Hanumant Giramkar was first appointed on 05 Jul 2017 as Director at Danlion Pharmaceuticals Private Limited.
The current boards of Satveek Hanumant Giramkar's companies include Jitendra Kalpnath Singh (Danlion Pharmaceuticals Private Limited), Premchand Ramchandra Bhusanar (Danlion Pharmaceuticals Private Limited).